An increased occurrence of ALS after long-term use of TNF-alpha inhibitors in rheumatic arthritis, is suggested to be a consequence of deficient TNF-alpha mediated neuronal protection (52). This evidence concerns the gene TNF and amyotrophic lateral sclerosis.